| Product Code: ETC071562 | Publication Date: Jun 2021 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The South Korea Infectious Disease Rapid Diagnostic Testing Market was estimated at USD 1438 Million in 2025 and is projected to reach USD 2054 Million by 2032, growing at a CAGR of 5.2% from 2026 to 2032. This trajectory is fueled by an increasing burden of infectious diseases, particularly in the wake of the COVID-19 pandemic, which has heightened awareness around early detection methods. Furthermore, advancements in diagnostic technologies and a robust healthcare system are pushing the demand for rapid testing solutions across the nation.
The South Korean Infectious Disease Rapid Diagnostic Testing market has shown stable growth, reflecting a compound annual growth rate of around 6.0% from 2021 through 2023, with a slight uptick to 6.1% in 2023 and 2024. This positive trend can be attributed to heightened consumer awareness of infectious diseases and the increasing investments in healthcare infrastructure and technology. As the nation continues to prioritize public health, the market is expected to see modest fluctuations; for instance, a slight decline to 5.7% in 2025 may stem from market saturation. However, the landscape is projected to stabilize again, with growth rates peaking at 6.4% in both 2030 and 2031, driven by advancements in digitalization and a robust policy focus on epidemic preparedness.
This graph highlights how the South Korea Infectious Disease Rapid Diagnostic Testing Market has steadily grown over the past five years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | 6.0% | Growing renewable energy integration projects |
| 2022 | 6.0% | Increasing smart city development projects |
| 2023 | 6.1% | Rising electricity demand across industries |
| 2024 | 6.1% | Increasing smart city development projects |
| 2025 | 5.7% | Rapid growth in telecom and data center sectors |
| 2026 | 6.2% | Expansion of manufacturing activities |
| 2027 | 6.2% | Rapid growth in telecom and data center sectors |
| 2028 | 6.2% | Expansion of manufacturing activities |
| 2029 | 5.9% | Rapid growth in telecom and data center sectors |
| 2030 | 6.4% | Increasing industrial automation investments |
| 2031 | 6.4% | Growing urbanization and commercial development |
| 2032 | 6.3% | Expansion of manufacturing activities |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The South Korean market for infectious disease rapid diagnostic testing is currently characterized by a dynamic and rapidly evolving landscape. With the ongoing emphasis on quick and accurate disease detection, healthcare providers are increasingly adopting advanced testing solutions that cater to diverse infectious diseases.
The push towards point-of-care testing is reshaping the diagnostic framework in South Korea, with significant investments directed toward research and development. This approach not only expedites diagnosis but also enhances patient management and control of infectious disease outbreaks.
Despite the promising growth potential, the South Korean Infectious Disease Rapid Diagnostic Testing Market is not without its challenges. Regulatory hurdles can lead to delays in product approvals, hampering the timely introduction of new diagnostic solutions. Additionally, competition among established players poses a significant barrier for new entrants. In rural areas, limited access to healthcare facilities may restrict the adoption of rapid testing technologies, while the costs associated with these tests can deter patients seeking timely diagnostics. Ensuring accuracy and reliability remains paramount, as any discrepancies in results can have severe implications for public health and patient care.
The market is witnessing a noteworthy shift towards point-of-care testing, driven by demand for rapid and precise diagnosis of infectious diseases. Advanced technologies such as nucleic acid amplification tests and antigen testing kits are gaining traction, allowing for quicker results with enhanced reliability. There is also a burgeoning interest in expanding the range of detectable diseases, including respiratory infections and tropical diseases. Collaborations between diagnostic companies and healthcare providers are increasingly becoming common, aiming to improve accessibility and distribution networks of rapid testing solutions throughout South Korea.
The landscape offers considerable investment opportunities, especially as the demand for accurate diagnostic solutions continues to surge. Companies focusing on the development and manufacturing of rapid diagnostic tests for infectious diseases are well-positioned for growth. Furthermore, strategic partnerships with healthcare facilities and government agencies can amplify market penetration and bolster growth prospects. The increasing prevalence of infectious diseases further underscores the necessity for timely detection, creating a robust market for innovative rapid testing technologies.
The South Korean government has undertaken significant measures to promote and regulate the Infectious Disease Rapid Diagnostic Testing Market. The Ministry of Food and Drug Safety (MFDS) plays a crucial role in overseeing the approval and quality assurance of diagnostic tests. In light of the COVID-19 crisis, the government accelerated the approval processes for diagnostic solutions and has financially supported local manufacturers to enhance production capabilities. Additionally, ongoing investments in research and development initiatives underscore the government’s commitment to fostering innovation and ensuring the availability of effective diagnostic tools to combat infectious diseases.
Looking ahead to the years between 2026 and 2032, the South Korea Infectious Disease Rapid Diagnostic Testing Market is poised for substantial growth. With the continuous rise in the prevalence of infectious diseases and the amplified focus on early detection strategies, the demand for rapid testing solutions is likely to expand. The evolution of point-of-care testing technologies and ongoing advancements in healthcare infrastructure are expected to further propel market dynamics. The COVID-19 pandemic has underscored the critical importance of rapid diagnostics, suggesting that the sector will continue to innovate and adapt to meet the changing needs of healthcare delivery.
Recent developments within the South Korea Infectious Disease Rapid Diagnostic Testing Market indicate a growing trend toward the integration of advanced technologies in diagnostic solutions. Companies are investing heavily in R&D to enhance the sensitivity and specificity of tests. There is also an increased emphasis on collaborative efforts between diagnostic firms and healthcare systems to facilitate more effective distribution networks. These trends are expected to solidify the position of rapid diagnostic testing within the broader healthcare landscape of South Korea.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Infectious Disease Rapid Diagnostic Testing Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, 2022 & 2032F |
3.3 South Korea Infectious Disease Rapid Diagnostic Testing Market - Industry Life Cycle |
3.4 South Korea Infectious Disease Rapid Diagnostic Testing Market - Porter's Five Forces |
3.5 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By Form, 2022 & 2032F |
3.6 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.7 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 South Korea Infectious Disease Rapid Diagnostic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in South Korea |
4.2.2 Growing awareness about the importance of rapid diagnostic testing |
4.2.3 Technological advancements in rapid diagnostic testing |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for diagnostic tests |
4.3.2 High cost associated with rapid diagnostic testing |
4.3.3 Limited access to healthcare facilities in certain regions of South Korea |
5 South Korea Infectious Disease Rapid Diagnostic Testing Market Trends |
6 South Korea Infectious Disease Rapid Diagnostic Testing Market, By Types |
6.1 South Korea Infectious Disease Rapid Diagnostic Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2022-2032F |
6.1.4 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Instruments, 2022-2032F |
6.1.5 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Services and Software, 2022-2032F |
6.2 South Korea Infectious Disease Rapid Diagnostic Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Immunodiagnostics, 2022-2032F |
6.2.3 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Clinical Microbiology, 2022-2032F |
6.2.4 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By PCR, 2022-2032F |
6.2.5 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By INAAT, 2022-2032F |
6.2.6 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2022-2032F |
6.2.7 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Other Technologies, 2022-2032F |
6.3 South Korea Infectious Disease Rapid Diagnostic Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Physician Offices, 2022-2032F |
6.3.3 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Reference Laboratories, 2022-2032F |
6.3.4 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.5 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Academic and Research Institutes, 2022-2032F |
6.3.6 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenues & Volume, By Others, 2022-2032F |
7 South Korea Infectious Disease Rapid Diagnostic Testing Market Import-Export Trade Statistics |
7.1 South Korea Infectious Disease Rapid Diagnostic Testing Market Export to Major Countries |
7.2 South Korea Infectious Disease Rapid Diagnostic Testing Market Imports from Major Countries |
8 South Korea Infectious Disease Rapid Diagnostic Testing Market Key Performance Indicators |
8.1 Adoption rate of rapid diagnostic testing by healthcare facilities |
8.2 Number of partnerships between diagnostic test manufacturers and healthcare providers |
8.3 Rate of development of novel rapid diagnostic testing technologies and products |
9 South Korea Infectious Disease Rapid Diagnostic Testing Market - Opportunity Assessment |
9.1 South Korea Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 South Korea Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By Technology, 2022 & 2032F |
9.3 South Korea Infectious Disease Rapid Diagnostic Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 South Korea Infectious Disease Rapid Diagnostic Testing Market - Competitive Landscape |
10.1 South Korea Infectious Disease Rapid Diagnostic Testing Market Revenue Share, By Companies, 2025 |
10.2 South Korea Infectious Disease Rapid Diagnostic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here